EUFOREA consensus on biologics for CRSwNP with or without asthma
WJ Fokkens, V Lund, C Bachert, J Mullol, L Bjermer… - Allergy, 2019 - Wiley Online Library
Novel therapies such as type 2 targeting biologics are emerging treatment options for
patients with chronic inflammatory respiratory diseases, fulfilling the needs of severely …
patients with chronic inflammatory respiratory diseases, fulfilling the needs of severely …
Epidemiology of chronic rhinosinusitis: prevalence and risk factors
AR Sedaghat, EC Kuan, GK Scadding - The Journal of Allergy and Clinical …, 2022 - Elsevier
Knowledge of chronic rhinosinusitis (CRS) epidemiology may directly impact patient care:
aiding patient identification and establishing accurate diagnosis as well as informing …
aiding patient identification and establishing accurate diagnosis as well as informing …
Two‐year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months
RJL van der Lans, JJ Otten, GFJPM Adriaensen… - Allergy, 2023 - Wiley Online Library
Background Dupilumab is an anti‐T2‐inflammatory biological registered for chronic
rhinosinusitis (CRS) with nasal polyps (CRSwNP), indicated by integrated CRS‐care …
rhinosinusitis (CRS) with nasal polyps (CRSwNP), indicated by integrated CRS‐care …
Highlights in the advances of chronic rhinosinusitis
X Xu, S Reitsma, DY Wang, WJ Fokkens - Allergy, 2021 - Wiley Online Library
Chronic rhinosinusitis (CRS) is a complex upper airway inflammatory disease with a broad
spectrum of clinical variants. As our understanding of the disease pathophysiology evolves …
spectrum of clinical variants. As our understanding of the disease pathophysiology evolves …
Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic—An EAACI position paper
Background Chronic rhinosinusitis is regarded as a chronic airway disease. According to
WHO recommendations, it may be a risk factor for COVID‐19 patients. In most CRSwNP …
WHO recommendations, it may be a risk factor for COVID‐19 patients. In most CRSwNP …
[HTML][HTML] Positionspapier: Anwendung von Biologika bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem–Empfehlungen …
L Klimek, U Förster-Ruhrmann, S Becker… - Laryngo-Rhino …, 2020 - thieme-connect.com
Hintergrund Die chronische Rhinosinusitis (CRS) betrifft weltweit ca. 5–12% der
Allgemeinbevölkerung und wird traditionell eingeteilt in einen Phänotyp ohne (CRSsNP) …
Allgemeinbevölkerung und wird traditionell eingeteilt in einen Phänotyp ohne (CRSsNP) …
Epidemiology and aetiology of chronic rhinosinusitis in Asia—A narrative review
J Chee, KW Pang, T Low, DY Wang… - Clinical …, 2023 - Wiley Online Library
Background Despite having a similar prevalence to Western populations, literature on
chronic rhinosinusitis (CRS) in the Asian population is sparse. There is limited data on the …
chronic rhinosinusitis (CRS) in the Asian population is sparse. There is limited data on the …
EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
Background: The European Position Papers on Rhinosinusitis from 2005, 2007 and 2012
have had a measurable impact on the way this common condition with high impact on …
have had a measurable impact on the way this common condition with high impact on …
[HTML][HTML] Indicating biologics for chronic rhinosinusitis with nasal polyps (CRSwNP) Recommendations by German allergy and ORL societies AeDA and DGHNO for …
L Klimek, U Förster-Ruhrmann, AG Beule… - Allergo Journal …, 2022 - Springer
Background Chronic rhinosinusitis with nasal polyps (CRSwNP), an inflammatory disease of
the paranasal mucosa, is primarily characterized by type 2 inflammation. Three antibodies …
the paranasal mucosa, is primarily characterized by type 2 inflammation. Three antibodies …
[HTML][HTML] BMI as a risk factor for the development of chronic rhinosinusitis: a prospective population-based study
UKE Clarhed, L Schiöler, K Torén, AKM Fell… - European Archives of …, 2022 - Springer
Purpose Obesity is a growing, global health problem and previous cross-sectional studies
have demonstrated an association between obesity and chronic rhinosinusitis (CRS). There …
have demonstrated an association between obesity and chronic rhinosinusitis (CRS). There …